<?xml version="1.0" encoding="UTF-8"?>
<ref id="B128-vaccines-08-00468">
 <label>128.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Segain</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Raingeard de la Bletiere</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Bourreille</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Leray</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Gervois</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Rosales</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ferrier</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Bonnet</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Blottière</surname>
    <given-names>H.M.</given-names>
   </name>
   <name>
    <surname>Galmiche</surname>
    <given-names>J.P.</given-names>
   </name>
  </person-group>
  <article-title>Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn’s disease</article-title>
  <source>Gut</source>
  <year>2000</year>
  <volume>47</volume>
  <fpage>397</fpage>
  <lpage>403</lpage>
  <pub-id pub-id-type="doi">10.1136/gut.47.3.397</pub-id>
  <pub-id pub-id-type="pmid">10940278</pub-id>
 </element-citation>
</ref>
